Gilead Sciences

YTD

ALL

Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO

Daniel P. O'Day

CEODaniel P. O'Day

Employees

17,600

Employees17,600

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1987

Founded1987

Employees

17,600

Employees17,600

GILD Key Statistics

Market cap

139.93B

Market cap139.93B

Price-Earnings ratio

24.08

Price-Earnings ratio24.08

Dividend yield

2.72%

Dividend yield2.72%

Average volume

5.92M

Average volume5.92M

High today

$114.50

High today$114.50

Low today

$112.31

Low today$112.31

Open price

$114.00

Open price$114.00

Volume

6.13M

Volume6.13M

52 Week high

$119.96

52 Week high$119.96

52 Week low

$72.43

52 Week low$72.43

Analyst ratings

68%

of 28 ratings

Buy

67.9%

Hold

32.1%

Sell

People also own

Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals